Latest Financial Performance News

JB Hi-Fi Limited reported a robust FY2025 with revenue up 10% to $10.55 billion and net profit after tax rising 5.4% to $462.4 million. The company declared a fully franked final dividend and a special dividend, while announcing a CEO succession plan.

Iress Limited reported a stable half-year profit for 2025, maintaining net earnings despite a slight revenue dip and ongoing divestments. The company strengthened its balance sheet through debt reduction and declared a healthy interim dividend, while exploring potential acquisition opportunities.

Charter Hall Social Infrastructure REIT (CQE) reported steady FY25 results with a 15.2 cents per unit distribution and announced a 10.5% increase in guidance for FY26, underpinned by strategic acquisitions and a robust debt refinancing.

Charter Hall Social Infrastructure REIT (CQE) reported solid FY25 results, highlighted by strategic acquisitions, a successful $900 million debt refinancing, and a 10.5% lift in distribution guidance for FY26.

CAR Group Limited has reported solid full-year FY25 results with revenue surpassing AUD 1.18 billion and adjusted NPAT rising to AUD 377 million, underpinned by global marketplace strength and strategic innovation. The company projects continued double-digit growth in FY26, driven by technology investments and market expansion.

CAR Group Limited has reported strong FY25 financial results with double-digit revenue and earnings growth across all key markets, while preparing for a leadership change. The company’s optimistic FY26 outlook underscores confidence in sustained expansion driven by innovation and market leadership.

CAR Group Limited reported a strong FY25 with revenue up 8% to $1.18 billion and net profit after tax rising 12% to $293 million, while announcing a leadership transition as CEO Cameron McIntyre steps down.

Cash Converters has expanded its Australian footprint by acquiring 14 franchise stores across key states, reinforcing its strategy to grow earnings and consumer lending.

Invex Therapeutics reports a significantly reduced net loss for FY25, driven by lower R&D costs after closing its Phase III trial, while advancing promising pre-clinical Alzheimer’s research through a collaboration with Tessara Therapeutics.

ResMed Inc. reported a robust 10% increase in revenue to $5.15 billion for fiscal 2025, driven by strong demand in sleep and breathing health devices and residential care software. The company also expanded its diagnostic capabilities with the acquisition of VirtuOx, positioning itself for further growth in home-based health solutions.

Ariadne Australia Limited anticipates a near breakeven total comprehensive income for FY25, balancing solid profits with significant portfolio losses and partnership costs.

Wrkr Limited is raising approximately A$15 million through an institutional placement to accelerate growth amid upcoming Payday Super reforms and market opportunities.